Singapore, April 15 -- JelloX Biotech Inc., aTaiwan-based startup at the forefront of cancer pathology, is opening a lab in the Discovery Oasis biotechnology space inPhoenix, Arizona.

An expansive 120-acre development, Discovery Oasis is envisioned as a biotechnology corridor of collaboration to advance groundbreaking solutions to humanity's most complex medical challenges. With around 1,100 square feet of space housing some of its most advanced equipment, JelloX will leverage its new lab for applying cutting-edge technologies like 3D imaging and AI to cancer pathology.

"Medical problems like cancer require many parties working together to create better treatments and patient care," commented Dr.Yen-Yin Lin, CEO of JelloX. "With all the...